Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP | P19971 | 5/20 | 0.65 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.43 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.43 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6905301 | 0.94 | TYMP (0.58) | TYMPSLC29A1HIF1AADORA3 | |
| SCHEMBL2239678 | 0.94 | TYMP (0.58) | TYMPSLC29A1HIF1AADORA3 | |
| SCHEMBL4826069 | 0.94 | TYMP (0.58) | TYMPSLC29A1HIF1AADORA3 | |
| SCHEMBL532674 | 0.94 | TYMP (0.58) | TYMPSLC29A1HIF1AADORA3 | |
| SCHEMBL735543 | 0.89 | TYMP (0.64) | TYMPSLC29A1HIF1AADORA3 | |
| SCHEMBL29720432 | 0.86 | TYMP (0.63) | TYMPSLC29A1POLBADORA3P2RY1 | |
| SCHEMBL11040442 | 0.86 | TYMP (0.63) | TYMPSLC29A1POLBADORA3P2RY1 | |
| SCHEMBL7065756 | 0.85 | TYMP (0.71) | TYMPHIF1APOLBADORA3ENPP1 | |
| SCHEMBL7065752 | 0.85 | TYMP (0.71) | TYMPHIF1APOLBADORA3ENPP1 | |
| SCHEMBL22392968 | 0.84 | TYMP (0.74) | TYMPSLC29A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3700536-A1 | COMPOSITIONS AND METHODS OF MODULATING THE IMMUNE RESPONSE BY ACTIVATING ALPHA PROTEIN KINASE 1 | Shanghai Yao Yuan Biotechnology Co., Ltd. (CN) | 2020-09-02 | — | — | EP | disclosed |